Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China
· Delayed Price · Currency is CNY 27.95
-0.44 (-1.55%)
Mar 9, 2026, 4:00 PM EDT
SHA:603207 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | 213.5 | 205.27 | 203.63 | 175.18 | 126.27 | 159.93 | Upgrade
|
| Depreciation & Amortization | 2.8 | 2.8 | 3.23 | 3.65 | 4.17 | 4.08 | Upgrade
|
| Other Amortization | 0.24 | 0.24 | 0.29 | 0.25 | 0.24 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0 | - | -0.25 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.27 | 0.06 | -0.15 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.02 | -0.02 | -2.25 | -2.96 | -2.83 | -3.67 | Upgrade
|
| Stock-Based Compensation | 0.79 | 0.79 | 1.99 | 4.08 | 43.78 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.22 | 0.22 | 0.17 | 1.37 | -0.71 | -0.06 | Upgrade
|
| Other Operating Activities | -41.86 | 0.1 | 0.13 | 0.05 | 0.08 | -0 | Upgrade
|
| Change in Accounts Receivable | -6.76 | -6.76 | -4.39 | -33.68 | 12.74 | 3.78 | Upgrade
|
| Change in Inventory | 4.61 | 4.61 | 7.2 | -4.12 | -13.25 | 2.51 | Upgrade
|
| Change in Accounts Payable | 5.45 | 5.45 | -9.15 | -6.63 | 9.51 | 10.95 | Upgrade
|
| Operating Cash Flow | 178.48 | 212.21 | 200.26 | 137.2 | 179.51 | 177.09 | Upgrade
|
| Operating Cash Flow Growth | -17.02% | 5.97% | 45.96% | -23.57% | 1.37% | 16.89% | Upgrade
|
| Capital Expenditures | -65.57 | -83.94 | -80.15 | -61.59 | -12.48 | -38.58 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.11 | - | - | - | 0.46 | - | Upgrade
|
| Investment in Securities | -20 | -450.1 | 107.27 | 54.02 | -97.57 | 37.39 | Upgrade
|
| Other Investing Activities | 3.66 | 3.09 | -0.72 | 0.9 | 5.19 | 1.33 | Upgrade
|
| Investing Cash Flow | -81.8 | -530.95 | 26.4 | -6.67 | -104.4 | 0.14 | Upgrade
|
| Short-Term Debt Issued | - | 1.65 | - | - | - | - | Upgrade
|
| Total Debt Issued | 1.65 | 1.65 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.23 | -0.45 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.43 | 1.43 | -0.45 | - | - | - | Upgrade
|
| Issuance of Common Stock | 17.96 | 472.36 | 1.98 | - | 3.4 | - | Upgrade
|
| Common Dividends Paid | -240.84 | - | - | -111.39 | -84.56 | -137.71 | Upgrade
|
| Other Financing Activities | -14.66 | -10.73 | -4.3 | -5.28 | -1.2 | - | Upgrade
|
| Financing Cash Flow | -236.12 | 463.06 | -2.78 | -116.67 | -82.36 | -137.71 | Upgrade
|
| Net Cash Flow | -139.45 | 144.31 | 223.87 | 13.85 | -7.25 | 39.52 | Upgrade
|
| Free Cash Flow | 112.9 | 128.27 | 120.11 | 75.61 | 167.03 | 138.51 | Upgrade
|
| Free Cash Flow Growth | -11.15% | 6.79% | 58.86% | -54.73% | 20.59% | -5.64% | Upgrade
|
| Free Cash Flow Margin | 22.38% | 27.03% | 25.45% | 16.55% | 41.57% | 38.34% | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.96 | 1.00 | 0.63 | 1.39 | - | Upgrade
|
| Cash Income Tax Paid | 78.2 | 62.86 | 81.73 | 71.64 | 59.18 | 51.17 | Upgrade
|
| Levered Free Cash Flow | 131.01 | 114.93 | 106.55 | -37.4 | 211.19 | 89.01 | Upgrade
|
| Unlevered Free Cash Flow | 131.02 | 114.95 | 106.58 | -37.36 | 211.25 | 89.01 | Upgrade
|
| Change in Working Capital | 2.79 | 2.79 | -6.92 | -44.7 | 8.44 | 17.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.